Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)

หัวข้อวิจัย

Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)หัวข้อวิจัย

ฤทธิ์ต้านเนื้องอกของเซลล์ T ของตัวรับแอนติเจนไคเมอริกที่กำหนดเป้าหมาย Mucin-1 ด้วยแอนติบอดี IgG ต่อต้าน PD-1 ที่ปลดปล่อยตัวเอง

Research Topics Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody Researchers Nattarika Khuisangeam Institute Medical Microbiology Interdisciplinary and International Program, Graduate School,...
อ่านต่อไป

Development of CAR T-cell Products for the Treatment of Hematologic Malignancies to Enhance the Competitiveness of Thailand’s Advanced Therapy Medicinal Products (ATMP) Industry (Phase 1)

Research Topics Development of CAR T-cell Products for the Treatment of Hematologic Malignancies to Enhance the Competitiveness of Thailand’s Advanced Therapy Medicinal Products (ATMP) Industry (Phase 1) Researchers Koramit...
อ่านต่อไป

Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus

Research Topics Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus Researchers Wannagam Kijthanamongkolchai Institute Faculty...
อ่านต่อไป

Expanding Horizons in Immunotherapy: Integrating Advanced Cell Engineering, Reprogramming, and Adjunct Therapies for Cancer and inflammatory-mediated diseases

Research Topics Expanding Horizons in Immunotherapy: Integrating Advanced Cell Engineering, Reprogramming, and Adjunct Therapies for Cancer and inflammatory-mediated diseases Researchers Prof.Nattiya Hirankarn and TTCI team Institute Faculty of Medicine,...
อ่านต่อไป

Clinical resolution of autoimmune choroiditis and multiorgan involvement of refractory systemic lupus erythematosus patient treated with CD19CAR-T incorporated CD28/CD40 signaling molecules

Research Topics Clinical resolution of autoimmune choroiditis and multiorgan involvement of refractory systemic lupus erythematosus patient treated with CD19CAR-T incorporated CD28/CD40 signaling molecules Researchers Jakrawadee Julamanee,Panarat Noiperm,Watsamon Uraiwan,Porntip Intapiboon,Parichat...
อ่านต่อไป

Prolonged CAR-T cell expansion and stemness in heavily pretreated relapsed/refractory B-ALL and B-NHL patients treated with CD19CAR incorporated CD28/CD40 co-stimulatory molecule: A preliminary outcome of academic PSU CD19CAR-T cell

Research Topics Prolonged CAR-T cell expansion and stemness in heavily pretreated relapsed/refractory B-ALL and B-NHL patients treated with CD19CAR incorporated CD28/CD40 co-stimulatory molecule: A preliminary outcome of academic PSU...
อ่านต่อไป

Feasibility of generation and expansion of hematopoietic stem cell-derived natural killer cells for a potential alternative cell source of cancer immunotherapy

Research Topics Feasibility of generation and expansion of hematopoietic stem cell-derived natural killer cells for a potential alternative cell source of cancer immunotherapy Researchers Suppanut Komjakraphan,Poonnattha Anantasaeree,Kajornkiat Maneechai,Panarat Noiperm,Watsamon...
อ่านต่อไป